Enhanced tumor killing by Apo2L/TRAIL and CPT-11 co-treatment is associated with p21 cleavage and differential regulation of Apo2L/TRAIL ligand and its receptors
Year: 2002
Type: article
Source: Oncogene
Institution: Genentech
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
Funder: Genentech
OpenAlex ID: W2322345488
